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Self-management is critical if people with diabetes are to minimise their risk of macrovascular and microvascular complications,
yet adherence to self-management recommendations is suboptimal. Understanding the predictors of optimal diabetes self-
management in specific populations is needed to inform effective interventions. This study investigated the role of demographic
and clinical characteristics, illness perceptions, and self-efficacy in explaining adherence to self-management recommendations
among people with poorly controlled diabetes in North West of England. Illness perceptions and self-efficacy data were collected
using validated questionnaires and clinical data were obtained from hospital records. Correlations were used to investigate bivariate
relationships between independent variables and self-management, and multiple regression techniques were used to determine
demographic and psychosocial predictors of self-management. Various demographic and clinical characteristics were associated
with adherence to self-management recommendations. In particular, employment status explained 11%of the variation in adherence
to foot care whilst diabetes treatment category explained 9% of exercise and 21% of the variations in SMBG recommendations.
Also, 22% and 8% of the variations in overall self-management were explained by illness perceptions and self-efficacy beliefs,
respectively. Illness perceptions and self-efficacy beliefs of people with poorly controlled diabetes are important predictors of their
self-management behaviours and could potentially guide effective interventions.
1. Introduction
Diabetes is a complex chronic condition with serious physi-
cal, psychological, and clinical complications for individuals
affected [1]. Irrespective of the type of diabetes, appropriate
self-management is critical if individuals with the condi-
tion are to minimise their risk of diabetes complications
and ensure improved health outcomes overall. Key areas
of the diabetes self-management regime include significant
behavioural and lifestyle changes such as meal and dietary
planning, daily regulation of physical activity, appropriate
use of recommended medication, and, where applicable,
monitoring and interpretation of blood glucose and use of
its results to inform decisions such as adjusting medications,
diet, and physical activity levels [2]. There is evidence that
adherence to supportive but often complex self-management
plans in diabetes is suboptimal [3, 4] which raises ques-
tions about potential predictors of effective self-management,
which have particular importance for people whose diabetes
presents as poorly controlled.
In addition to the drastic behavioural and lifestyle
changes required following diagnosis with diabetes, uncer-
tainties about the future and, indeed, thoughts and/or
experiences of the acute and chronic complications asso-
ciated with the condition often lead to severe coping
and other psychosocial problems for individuals affected.
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Thus, promoting effective self-management requires that
patients are equipped with a repertoire of relevant knowledge
and skills through appropriate self-management education
and support systems [2, 5]. Specifically, individuals with
diabetes need a clear understanding of the tasks involved in
self-management, a practical appreciation of how to perform
each self-management task on daily basis, some of which
could be complex, and the ability to determine when and
under what circumstances to undertake a particular self-
management task, as well as decision-making and problem-
solving skills [6, 7]. Even with these skills, adherence to self-
management recommendations is influenced by several other
factors including (but not limited to) personal and sociode-
mographic characteristics, individual’s own perceptions and
expectations about the given illness, and their perceived
confidence in relation to whether or not they are able to per-
form the given self-management task (concept of self-effi-
cacy) [8–10].
Self-efficacy is a cognitive theory that was put forward
in the 1970s by Bandura [11]. The concept asserts that indi-
viduals’ level of confidence in relation to their ability to
perform a given task such as a specific health behaviour is
an important determinant of whether or not they initiate and
engage in that behaviour. Because of its potential to influence
the desired health outcomes, the concept of self-efficacy
is of great interest to researchers, health providers, and
promoters in search of theoretical frameworks to anchor and
guide policy and practice. Particularly, improvements in self-
efficacy of patients have been used as amechanism to enhance
behaviour change and improve adherence to chronic dis-
ease self-management recommendations, including those for
diabetes [6, 12, 13]. Indeed, self-management interventions
developed with self-efficacy as the underpinning theoretical
framework have shown promise, albeit inconclusive. For
instance, Lorig and Holman [6] observed that self-efficacy
on its own significantly influences the health status of people
with long-term conditions. Specifically they found that self-
efficacy levels at baseline as well as changes in self-efficacy
achieved through self-management intervention significantly
predicted health status. Recently, others have also reported
modest to strong relationships between self-efficacy and self-
management behaviours among adults with type 2 diabetes
[14, 15] and adolescents with type 1 diabetes [9, 16]. In spite
of the plethora of evidence on the relationship between self-
efficacy and self-management, the majority of studies have
been conducted in the general diabetes population, regardless
of patient demographics and diabetes control outcomes.
Thus, it is not clear if such a relationship will exist in a sample
exclusively drawn from a population with poorly controlled
diabetes.
In addition to self-efficacy, another cognitive framework
useful for explaining health-related behaviour choices of indi-
viduals and perhaps populations is the illness representation
model. This concept is based on the common-sense model
of illness representation which evolved from the work of
Howard Leventhal and colleagues’ investigating impact of
fear messages on individuals’ inclination to perform recom-
mended health behaviour [17]. They observed that a health
threatening stimulus provoked, simultaneously, the search
for both emotional and cognitive representations of the
health threat among their study participants. Leventhal noted
that the parallel processing of the cognitive and emotional
representations of the threat served to generate strategies
and coping plans with which to eliminate the threat. Much
of research on this framework has been on patient samples;
however, in principle, a health threat (stimulus) could result
from experiencing symptoms of an illness, being diagnosed
with an illness, or being potentially at risk of illness. Illness
representations could emerge from three types of informa-
tion: “lay” knowledge already possessed by an individual,
authoritative information obtained from external sources
(e.g., doctor and book), and personal experience, whether
current or previous, including outcomes of that experience. It
is contended that an individual’s representations of an illness
are based on their personal perceptions and/or experiences
of the condition or other illness and should not necessarily
be expected to conform to existing medical facts about the
given illness [18, 19].
Research has reliably shown that an individual represents
an illness along five cognitive dimensions [17]: identity, the
label and symptoms associatedwith the illness; consequences,
the individual’s perception of how the illness might affect
their lives and any likely outcome; Control, the individual’s
perception of the level of control or influence they have over
the course of the illness, including its cure or treatment;
timeline, the length of time individuals perceive their illness
will last (short-term or long-term); and Cause, individuals’
beliefs about what caused the illness. The emotional repre-
sentation component indicates patients’ attitude or state of
mind in response to the diagnosis or health threat (e.g., fear,
anxiety, or distress). Illness representations have been found
to significantly influence individual’s lifestyle and behaviour
choices, and the concept has subsequently been employed as
an effective mechanism for improving behaviour change and
other health outcomes [20–22]. Among people with diabetes,
illness representation has been reported to predict adherence
to recommended self-management behaviours, as well as
objective clinical outcomes, particularly glycaemic control
levels [23–26]. However, what is not clear is whether the
concept of illness representation is universal in terms of the
demographic and clinical profile of the patient population
studied. This is important if effective packages to support
coping and self-management of diabetes are to be put forward
by clinicians.
This study examined whether patient characteristics,
patients’ diabetes specific self-efficacy, or patients’ illness rep-
resentations would significantly influence self-management
behaviours of predominantly poorly controlled type 1 and
type 2 diabetes (from this point, type 1 and type 2 diabetes
will be referred to as diabetes, unless otherwise specified)
patients managed in acute trusts. We specifically aimed at
addressing 2 research questions. First, we sought to investi-
gate which sociodemographic and disease characteristics are
likely to influence diabetes specific self-efficacy, illness rep-
resentation, and self-management among individuals with
poorly controlled diabetes.Thenwe determinedwhether self-
efficacy and illness representations influence the degree of
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adherence to self-management recommendations among the
study population.
2. Materials and Methods
2.1. Study Participants and Procedures. This study was part of
a larger study that investigated the influence of work-related
factors on diabetes self-management. Thus, names and
addresses of potentially working adults (aged 25–65 years)
with diabetes were obtained from databases of two NHS
hospital trusts in the North West of England. Individuals
who did not have a record of severe mental (such as severe
depression) or cognitive disorder (such as dementia) and
could provide consent were contacted by post and invited
to participate in the study. Study packs containing invitation
letter, consent form, participant information sheet, stamped
self-addressed return envelope, and study questionnaires
were sent to potential participants.The invitation letter asked
patients to read the information sheet and if they agree to
participate in the study, sign the consent forms, complete
the questionnaires, and return them to the researchers in
the stamped envelope provided. After three weeks from
the date of postage, reminder letters and another pack of
questionnaires were sent to patients who did not respond.
Participant recruitment took place between July 2013 and
November 2013.
Relevant data were collected using a demographic and
disease characteristics questionnaire, the brief Illness Percep-
tions Questionnaire (IPQ) [27], the Summary of Diabetes
Self-care Activities (SDSCA) questionnaire [28], and the
Perceived Diabetes Self-Management Scale (PDSMS) [29].
Recent (last 6 months, if not last 12 months) data on gly-
caemic control (HbA1c), diabetes complication status (micro-
vascular), and comorbidities were obtained from partici-
pants’ medical records. Ethical approval was granted by the
North East-Newcastle & North Tyneside committee 1.
2.2. Study Questionnaires. The brief IPQ [27] is a nine-item
summarised and quick to administer version of the full illness
perception questionnaires [30, 31] used for assessing individ-
uals’ cognitive and emotional representations of an illness
such as diabetes. The first eight items of the questionnaire
examine patient’s perceptions of the timelines, consequences,
identity (symptom load), coherence (or understanding), and
emotions, each scored on a scale of 0 to 10. The ninth item
asks patients to rank in order of importance the 3 factors
that they believe to have caused their illness (in this case,
diabetes). Overall, high scores on the brief IPQ indicate a
more threatening or serious view of the illness, whereas low
scores reflect more benign view. Psychometric properties of
the instrument have been evaluated using a wide range of
patient populations including people with myocardial infarc-
tion, asthma, and diabetes. Six-week test-retest reliability
for individual components of the measure, as determined
by Pearson correlation coefficient, ranged between 0.42 and
0.75 and items of the brief IPQ correlated sufficiently with
equivalent component items of the full IPQ-R (ranging from
0.32 to 0.63), indicating good concurrent validity. Further,
various elements of the brief IPQ have been found to
significantly predict a range of health outcomes including
attendance at rehabilitation classes, time of return to work,
and quality of life among MI patients [27].
The SDSCA is a self-report measure and asks patients to
indicate howmany of the last seven days they fulfilled dietary,
exercise, self-monitoring of blood glucose (SMBG), and foot
care recommendations as advised by their diabetes health
care team (scored on a scale of 0 days–7 days). The revised
SDSCA used in this study consists of 11 carefully selected core
items which demonstrated sound psychometric properties
(internal consistency, predictive validity, and no ceiling/floor
effect) from seven previously published studies [28]. Of the 11
items of the SDSCA, four are for diet, two are for exercise,
two are for SMBG, two are for foot care, and one is for
smoking. In consonance with the number of days in a week,
each item (except smoking) is scored on a scale of zero
(participant has not performed the task in the last seven days)
to seven (participant has performed the task every day in
the past seven days). The item for smoking is binary (Yes/No
response) and asks whether participants smoked cigarette
during the past seven days. In this study, the scores for
specific dimension of self-management, diet, exercise, SMBG,
and foot care, were obtained from the average scores of all
relevant items combined. Scores for overall adherence to self-
management (overall self-management) were computed by
taking the average of diet, exercise, SMBG, and foot care.The
smoking itemwas not included in computing the dimension-
specific or the overall self-management scores.
The PDSMS [29] is an 8-item likert-type questionnaire
which was developed from the generic Perceived Medical-
Condition Self-Management Scale [32] for use with both
type 1 and type 2 diabetes populations. If fully completed,
total scores for the PDSMS range from 8 to 40 with high
scores indicating greater confidence in the individual’s abil-
ity to self-manage their diabetes. Psychometric evaluation
analyses showed reasonable correlations between responses
to the PDSMS and SDSCA and demographic characteristics,
demonstrating sufficient evidence of construct validity. The
PDSMS also showed good internal consistency (Cronbach’s
alpha = 0.83) among the mixed type 1 and type 2 diabetes
patient sample.
2.3. Statistical Methods. Data analyses were conducted using
the Statistical Package for Social Sciences (SPSS version 20,
IBM Corp.). Initial analyses were performed to investigate
normality and other assumptions of parametric statistical
tests where required. Bivariate correlations (Pearson’s cor-
relation coefficient (𝑟) for continuous variables, Spearman’s
rho (𝑃) for ordinal and continuous variables that were not
normally distributed, or point biserial (𝑟pb) for dichotomous
variables; see Table 1) were produced to examine univariate
relationships between dependent and independent variables.
Two methods of multiple regressions were used. First, step-
wise regressions were used to determine which sociode-
mographic characteristics best predict psychosocial depen-
dent variables (illness perceptions and self-efficacy) and
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Table 1: Bivariate relationships between sociodemographic and disease characteristic variables and psychosocial dependent variables.
Variable IP score PDSMS score Diet SMG Exercise SMG SMBG Foot SMG Overall SMG
Age −0.03 −0.02 0.03 −0.12 −0.01 0.24∗ 0.08
Sexpb 0.04 −0.10 0.12 0.03 0.18
∗ 0.02 0.16
Marital status
𝜌
0.16 −0.12 −0.14 −0.16 −0.07 −0.01 −0.11
Educational qualification
𝜌
−0.16 0.16 −0.09 0.12 −0.01 0.10 −0.02
Ethnicity 0.01 0.03 0.09 0.05 −0.05 0.22∗ 0.12
Employment status
𝜌
0.23∗ −0.09 −0.04 −0.20∗ −0.04 0.08 0.01
Diabetes type
𝜌
0.19∗ −0.20∗ 0.06 −0.23∗ −0.26∗∗ 0.13 −0.09
Diabetes treatment type
𝜌
0.21∗ −0.08 0.05 −0.14 0.39∗∗∗ 0.07 0.12
Duration since diagnosis −0.18 0.19∗ −0.01 0.05 0.33∗∗∗ 0.13 0.18
BMI status
𝜌
0.21∗ −0.13 −0.08 −0.19 −0.16 0.15 −0.10
HbA1c (%) categories
𝜌
−0.12 0.18 −0.18 0.22∗ 0.07 0.04 0.10
BP statuspb 0.07 −0.01 0.12 −0.01 −0.09 0.15 0.02
Retinopathy statuspb −0.01 0.03 −0.07 −0.04 0.11 0.07 0.07
Neuropathy statuspb 0.24
∗
−0.14 −0.11 −0.20∗ −0.08 0.13 −0.09
Nephropathy statuspb 0.14 −0.06 0.10 0.09 −0.04 0.05 0.12
IP score −0.16 −0.13 −0.01 0.04 −0.17
PDSMS score −0.16 0.19∗ 0.10 0.17 0.29∗∗
𝜌, spearman’s rho; pb, point biserial correlation coefficient; all other correlation coefficients are Pearson’s correlation coefficients.
∗
𝑝 value ≤ 0.05; ∗∗𝑝 value ≤ 0.01; ∗∗∗𝑝 value ≤ 0.001.
IP, illness perception; PDSMS, Perceived Diabetes Self-Management Scale; SMG, self-management; SMBG, self-monitoring of blood glucose.
adherence to self-management recommendations. Finally,
the enter method was used to determine the extent to
which illness perceptions or self-efficacy predicts adherence
to self-management recommendations in the study popula-
tion. Independent variables were entered irrespective of the
strength of the relationship in the bivariate correlations.
Based on relevant parameters of the main study, a min-
imumof 340 participants were required to achieve a precision
of 0.05 at 95% confidence interval, assuming 1 in 3 dia-
betes patients in the working-age range was in employment.
However, a minimum sample size of 128 is sufficient for the
analysis presented in this paper (see details in Section 3.2.2).
People with diabetes are not a homogenous group and
some questions of the SDSCA may not be relevant for some
specific groups. For instance, SMBG may not be recom-
mended for some patients, particularly individuals on oral
hypoglycaemic agents.Thus, prior to completing the SDSCA,
participants were asked to indicate (Yes/No/Not applicable)
whether they have ever been advised by their diabetes health-
care team to perform any of the recommended self-man-
agement tasks since diagnosis. Responses to this preliminary
questionwere then used to adjust for all analysis involving the
SDSCA.
3. Results and Discussions
3.1. Results
3.1.1. Demographic and Disease Characteristics of Study Par-
ticipants. A hundred and twenty-three individuals with dia-
betes (51% type 2) participated in the study. Just over half
(51%) of participants were male and nearly all participants
(96%) considered their ethnicity as white British. About a
quarter of participants (24%) had university level educa-
tional qualification and most (80%) were employed or self-
employed. On average, participants were 50 years old (mean
age: 50.24; SD = 10.84), had been diagnosed with diabetes
for 16 years (mean duration since diagnosis = 15.97 years;
SD = 10.62), and were on average obese as indicted by the
mean BMI = 31.76 (SD = 6.90). As expected of an exclusively
poorly controlled sample, average percentage HbA1c was
44.39 (SD= 14.22). Prevalence of diabetes related comorbidity
and complications were also high in the studied population
with over 80% of participants having blood pressure levels
considered either prehypertensive or hypertensive. Also, half
of participants had diabetic retinopathy, slightly more than
one in five (21%) had diabetic neuropathy, and 11% were
diagnosed with nephropathy.
3.1.2. Associations between Sociodemographic and Disease
Characteristic Variables and Psychosocial Dependent Vari-
ables. Bivariate correlations between demographic/disease
characteristics and individual components of illness repre-
sentations showed scores of significant relationships. Notably,
high educational attainment was associated with perception
of greater personal control (𝑃 = 0.21, 𝑝 value < 0.05) and
less concern about their illness (𝑃 = −0.22, 𝑝 value < 0.05).
Participants with type 1 diabetes tended to perceive their
diabetes as long-term (𝑟 = −0.26, 𝑝 value < 0.01) and had
perceptions of greater personal control (𝑟 = −0.29, 𝑝 value <
0.01), greater treatment control (𝑟 = −0.31, 𝑝 value < 0.01),
and greater understanding or illness coherence (𝑟 = −0.21,
Journal of Diabetes Research 5
𝑝 value< 0.05). As a surrogatemarker of illness severity, being
on a more complex treatment regimen was associated with
experiencing greater number of symptoms (𝑃 = 0.35, 𝑝 value
< 0.001). Longer duration since diagnosis was significantly
correlated with perceiving diabetes as long-term condition
(𝑟 = 0.28, 𝑝 value < 0.01) and perceptions of greater personal
control (𝑟 = 0.21, 𝑝 value < 0.05), treatment control (𝑟 =
0.20, 𝑝 value < 0.05), and greater understanding or coherence
about diabetes (𝑟 = 0.30, 𝑝 value < 0.01). High BMI was
associatedwith greater worries (concern) about diabetes (𝑃 =
0.22, 𝑝 value < 0.05), presence of neuropathy was associated
with perception of less treatment effectiveness (𝑟 = −0.29,
𝑝 value < 0.01), and presence of nephropathy was associated
with perceptions of greater consequences (𝑟 = 0.20, 𝑝 value
< 0.05) as a result of diabetes.
In terms of overall illness perception score, the univariate
relationships (see Table 1 column 2) indicate that, compared
to the unemployed/retired, participants who were employed
had more threatening representations about their diabetes
(see interpretation of brief IPQ in Section 2.2). Also having
type 2 diabetes, being on a more complex treatment regimen,
having higher BMI, and having neuropathy were associated
with a more threatening view of diabetes.
As shown in Table 2, a raft of significant relationships
between demographic/disease characteristics and illness per-
ceptions were observed in the multivariate regression anal-
yses. Demographic/disease characteristics explained 12% of
the variations in consequences, 56% of timeline, 38% of
personal control, 27% of treatment control, 17% of identity
(symptom load), 15% of concern, 14% of illness coher-
ence, and 9% of emotional representations among study
participants. A key demographic variable which predicted
variations in specific components of illness perceptions
was educational achievement. Compared with the lowest
educational attainment (primary/secondary education), col-
lege/sixth form graduates were less likely to represent their
diabetes as long-term (𝐵 = −0.50; 95% CI, −0.77–−0.24; 𝑝
value ≤ 0.001) and graduates from university/graduate were
more likely to report greater personal control of their diabetes
(𝐵 = 1.30; 95% CI, 0.29–2.30; 𝑝 value ≤ 0.01), whereas
graduates from polytechnic weremore likely to perceive their
diabetes with greater number of symptoms (𝐵 = −2.44; 95%
CI, −4.72–−0.15; 𝑝 value ≤ 0.05). In relation to disease or
clinical variables, treatment regimen, duration since diag-
nosis, microvascular complication status, type of diabetes,
BMI, and percentage HbA1c significantly contributed to a
range of specific illness representations. Diabetes treatment
category emerged as a significant predictor for most specific
components of illness perceptions. Specifically, there were
significant variations in consequences (𝐵 = 1.34; 95% CI,
0.20–2.48; 𝑝 value ≤ 0.05), timeline (𝐵 = −0.67; 95% CI,
−1.04–−0.30; 𝑝 value ≤ 0.001), personal control (𝐵 = 1.56;
95% CI, 0.12–3.00; 𝑝 value ≤ 0.05), identity (number of
symptoms experienced) (𝐵 = 1.86; 95%CI, 0.67–3.05;𝑝 value
≤ 0.01), and concern (𝐵 = −1.86; 95% CI, −2.81–−0.90 𝑝
value ≤ 0.001) between participants on one hypoglycaemic
tablet compared to people on more complex or advanced
treatment regimens (≥2 hypoglycaemic tablets, insulin, or
diabetic tablets and insulin). Longer duration since diagnosis
was associated with longer timeline perceptions (𝐵 = 0.02;
95% CI, 0.01–0.03; 𝑝 value ≤ 0.01), greater understanding
(coherence) about diabetes (𝐵 = 0.06; 95% CI, 0.02–0.11; 𝑝
value ≤ 0.01), and lower negative emotional response (𝐵 =
−0.09; 95% CI, −0.15–−0.03; 𝑝 value ≤ 0.01).
Employment status, diabetes type, diabetes treatment cat-
egory, BMI, and neuropathy status significantly contributed
to the overall illness perception scores. The multivariate rela-
tionships between demographic/disease characteristics and
overall illness perception as shown in Table 2 (row (ix)) indi-
cate that diabetes treatment category (1 diabetic tablet versus
diabetic tablets and insulin), nephropathy status, duration
since diagnosis, percentage HbA1c, and BMI significantly
contributed to variations in illness representation in the
study sample. Together, these variables explained 34% of the
variation in overall illness representation among the study
participants.
Diabetes type and duration since diagnosis significantly
correlated with self-efficacy scores in univariate analyses
(Table 1). Having type 1 diabetes and longer duration since
diagnosis was associated with higher confidence in patients’
ability to self-manage their diabetes. In the regression analysis
(see part (2) of Table 2), neuropathy status, duration since
diagnosis, and percentage HbA1c each contributed signif-
icantly in predicting patients’ perceived confidence (self-
efficacy). The three variables together explained 23% of the
variation in self-efficacy among the study participants.
3.1.3. Associations between Sociodemographic/Disease Char-
acteristic Variables and Adherence to Self-Management Rec-
ommendation. Anumber of sociodemographic/disease char-
acteristic variables significantly influenced participants’ self-
management behaviours in the univariate analysis as cap-
tured in Table 1. Older age was associated with greater
adherence to foot self-management and being female was
associated with greater frequency of SMBG. Consistent with
general expectations, participants with type 1 diabetes, those
with more complex treatment regimens and longer duration
since diagnosis, were also associated with higher frequency
of SMBG. Further, employment status, diabetes type, per-
centage HbA1c, and neuropathy status were also associated
with adherence to exercise recommendations. The multi-
variate analyses to determine which demographic/disease
characteristics predict self-management behaviours showed
that only diabetes treatment category and employment status
significantly contributed to variations in self-management
behaviours. As seen in Table 2 part (3), diabetes treatment
category explained small but significant proportions of the
variations in participants’ adherence to exercise (9%), SMBG
(21%), and overall self-management (7%) whilst employment
status explained 11% of the variation in adherence to foot care
recommendations.
3.1.4. Associations between (a) Illness Representations and Self-
Management Behaviours and (b) Self-Efficacy forDiabetes Self-
Management and Self-Management Behaviours. Multivariate
relationships between illness representation scores and mea-
sured diabetes self-management behaviours are shown in
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Table 2: Predicting illness perceptions, self-efficacy, and adherence to self-management recommendations from sociodemographic and
disease characteristics.
Predictor variable 𝐵 (SE) 95% CI 𝑝 value 𝛽 𝑅2
(1) Predicting illness perceptions from demographic/disease
characteristics
(i) Consequences and demographic/disease characteristics <0.01∗∗ 0.12
Constant 2.88 (0.41) 0.88–4.89 ≤0.01∗∗
Nephropathy status 2.54 (1.03) 0.48–4.59 0.02∗ 0.254
diabetic tablets + insulin versus 1 diabetic tablet 1.34 (0.57) 0.20–2.48 0.02∗ 0.242
HbA1c (%) 0.04 (0.02) 0.00–0.08 0.04∗ 0.212
(ii) Timeline and demographic/disease characteristics <0.001 0.56
Constant 9.78 (0.13) 9.55–10.05 <0.001∗∗∗
≥2 diabetic tablets versus 1 diabetic tablet −0.67 (0.19) −1.04–−0.30 0.001∗∗∗ −0.34
Primary/secondary versus college/sixth form −0.50 (0.13) −0.77–−0.24 <0.001∗∗∗ −0.36
Duration since diagnosis 0.02 (0.01) 0.01–0.03 <0.01∗∗ 0.29
(iii) Personal control and demographic/disease characteristics <0.001∗∗∗ 0.38
Constant 12.79 (1.16) 10.48–15.11 <0.001∗∗∗
Diabetes type −2.78 (0.51) −3.78–−1.79 <0.001∗∗∗ −0.56
HbA1c (%) −0.07 (0.02) −0.10–−0.04 <0.001∗∗∗ −0.39
Primary/secondary versus university/graduate 1.30 (0.51) 0.29–2.30 0.01∗∗ 0.23
≥2 diabetic tablets versus 1 diabetic tablet 1.56 (0.73) 0.12–3.00 0.03∗ 0.21
(iv) Treatment control and demographic/disease characteristics <0.001∗∗∗ 0.27
Constant 13.00 (1.17) 10.68–15.33 <0.001∗∗∗
Diabetes type −1.73 (0.49) −2.70–−0.75 0.001∗∗∗ −0.36
HbA1c (%) −0.05 (0.02) −0.09–−0.02 <0.01∗∗ −0.30
Neuropathy status −1.47 (0.59) −2.64–−0.30 0.01∗∗ −0.25
(v) Identity and demographic/disease characteristics ≤0.001∗∗∗ 0.17
Constant 4.63 (0.42) 3.79–5.17 <0.001∗∗∗
diabetic tablets and insulin versus 1 diabetic tablet 1.86 (0.60) 0.67–3.05 <0.01∗∗ 0.32
Primary/secondary versus polytechnic −2.44 (1.15) −4.72–−0.15 0.04∗ −0.22
(vi) Concern and demographic/disease characteristics <0.001∗∗∗ 0.15
Constant 8.22 (0.29) 7.65–8.79 <0.001∗∗∗
insulin versus 1 diabetic tablet −1.86 (0.48) −2.81–−0.90 <0.001∗∗∗ −0.39
(vii) Illness coherence and demographic/disease characteristics <0.01∗∗ 0.14
Constant 5.82 (0.50) 4.83–6.81 <0.001∗∗∗
Duration since diagnosis 0.06 (0.02) 0.02–0.11 <0.01∗∗ 0.30
Sex 1.05 (0.46) 0.14–1.96 0.02∗ 0.24
(viii) Emotional response and demographic/disease
characteristics <0.01
∗∗ 0.09
Constant 6.67 (0.60) 5.48–7.86 <0.001∗∗∗
Duration since diagnosis −0.09 −0.15–−0.03 <0.01∗∗ −0.30
(ix) Overall IP score and demographic/disease characteristics <0.001∗∗∗ 0.34
Constant 14.21 −3.09–31.51 0.11
diabetic tablets and insulin versus 1 diabetic tablet 6.82 (2.22) 2.40–11.23 <0.01∗∗ 0.29
Nephropathy status 10.98 (3.87) 3.27–18.70 <0.01∗∗ 2.84
Duration since diagnosis −0.21 (0.11) −0.42–0.00 0.06 −0.19
HbA1c (%) 0.27 (0.09) 0.10–0.44 <0.01∗∗ 0.32
BMI 0.48 (0.19) 0.11–0.86 0.01∗∗ 0.27
(2) Predicting PDSMS scores from demographic/disease
characteristics <0.001
∗∗∗ 0.23
Constant 31.87 (2.56) 26.77–36.98 <0.001∗∗∗
Neuropathy status −5.17 (1.63) −8.42–−1.92 <0.01∗∗ −0.32
Duration since diagnosis 0.17 (0.06) 0.05–0.29 <0.01∗∗ 0.29
HbA1c (%) −0.14 (0.05) −0.24–−0.03 0.01∗∗ −0.26
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Table 2: Continued.
Predictor variable 𝐵 (SE) 95% CI 𝑝 value 𝛽 𝑅2
(3)Which demographic/disease characteristics best predict
adherence to self-management recommendations?
(i) Diet/meal planning recommendations and
demographic/disease characteristics
No variable entered into the equation (no variable
significantly predicted diet)
(ii) Exercise recommendations and demographic/disease
characteristics <0.01
∗∗ 0.09
Constant 2.21 (0.31) 1.59–2.83 <0.001∗∗∗
Insulin versus 1 diabetic tablet 1.47 (0.52) 0.44–2.50 0.01∗∗ 0.31
(iii) Blood testing recommendations and demographic/disease
characteristics 0.21
Constant 5.17 (0.27) 4.63–5.71 <0.001∗∗∗
≥2 diabetic tablets versus 1 diabetic tablet −3.49 (0.75) −4.97–−2.00 <0.001∗∗∗ −0.46
(iv) Foot care recommendations and demographic/disease
characteristics <0.01
∗∗ 0.11
Constant 2.53 (0.26) 2.02–3.05 <0.001∗∗∗
Employed versus not in work due to long-term
illness/disability 2.32 (0.75) 0.82–3.81 <0.01
∗∗∗ 0.32
(v) Overall SMG recommendations and demographic/disease
characteristics 0.02
∗ 0.07
Constant 3.79 (0.15) 3.50–4.10 <0.001∗∗∗
≥2 diabetic tablets versus 1 diabetic tablet −0.99 (0.42) −1.83–−0.16 0.02∗ −0.26
∗
𝑝 value ≤ 0.05; ∗∗𝑝 value ≤ 0.01; ∗∗∗𝑝 value ≤ 0.001.
Table 3 part (1).The results suggest that illness representations
explain significant proportions of the variations in adherence
to SMBG (14%), feet care (18%), and overall self-management
(22%). Specifically longer timeline representations of diabetes
were associated with greater frequency of SMBG (𝐵 = 0.66;
95% CI, 0.07–1.25; 𝑝 value < 0.05). Greater sense of personal
control (𝐵 = 0.25; 95% CI, 0.04–0.46; 𝑝 value < 0.05) and
illness coherence (𝐵 = 0.28; 95% CI, 0.06–0.49; 𝑝 value <
0.01) was associated with better adherence to feet care. In
addition, greater perception of illness coherence (𝐵 = 0.19;
95%CI, 0.08–0.31;𝑝 value< 0.001) was associatedwith higher
adherence to overall self-management recommendations.
Results for relationships between self-efficacy for manag-
ing diabetes and self-reported adherence to self-management
recommendations (as in Table 3 part (2)) indicate that self-
efficacy is a predictor of patients’ adherence to diabetes self-
management recommendations. This is particularly signif-
icant for overall self-management in which self-efficacy
explained 8% of the variation in self-management among the
participants.
3.2. Discussion
3.2.1. Summary of Findings. This study investigated clinico-
sociodemographic and psychosocial predictors of self-
management behaviours among individuals with poorly con-
trolled diabetes receiving care at two acute trusts in North
West of England. In accordance with our research questions,
the findings suggest that participants whowere employed had
more threatening representations about their diabetes com-
pared with less economically active (unemployed/retired)
participants.
Participants with adverse or advanced clinical outcomes,
complex treatment regimen, being diagnosedwith nephropa-
thy, high hbA1c, and high BMI, were more likely to have
threatening representations about their diabetes.
Compared to participants with type 2 diabetes, individu-
als with type 1 diabetes expressed higher confidence in their
ability to self-manage their diabetes. Three clinical indica-
tors contributed significantly in predicting participants’ self-
efficacy for diabetes self-management, duration since diag-
nosis, neuropathy status, and HbA1c. Participants who have
been diagnosed with diabetes for a longer duration perceived
greater confidence in self-managing their diabetes, whereas
participants who have been diagnosed with neuropathy and
those with higher HbA1c perceived lower confidence in
their ability to self-manage the condition. Type of diabetes,
neuropathy status, duration since diagnosis, and HbA1c were
also confirmed as significant predictors of self-efficacy for
self-management of diabetes in multiple regression analyses.
A range of demographic (particularly, educational attain-
ment) and disease (treatment category, duration since diag-
nosis, microvascular complication status, type of diabetes,
BMI, and HbA1c) characteristics contributed significantly in
predicting patients’ representations about their diabetes.
A variety of demographic and disease characteristic
variables were significantly associated with participants’ self-
management behaviours. In particular, treatment category
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Table 3: Predicting adherence to recommended self-management behaviours from psychosocial variables (illness perceptions or self-
management-related self-efficacy).
Predictor variable 𝐵 (SE) 95% CI 𝑝-value 𝛽 𝑅2
(1) Predicting self-management from illness perceptions
Diet recommendations and illness perceptions 0.07∗ 0.13
Constant 5.43 (2.05) 1.37–9.48 0.01∗∗
Consequences 0.04 (0.08) −0.13–0.21 0.65 0.06
Timeline −0.26 (0.20) −0.64–0.13 0.19 −0.13
Personal control 0.01 (0.08) −0.15–0.17 0.93 0.01
Treatment control 0.03 (0.09) −0.15–0.17 0.73 0.04
Identity −0.10 (0.07) −0.24–0.03 0.13 −0.16
Concern −0.06 (0.08) −0.22–0.09 0.42 −0.09
Understand 0.21 (0.08) 0.05–0.37 0.01∗∗ 0.27
Emotional response 0.07 (0.07) −0.07–0.21 0.33 0.12
Exercise recommendations and illness perceptions 0.14 0.11
Constant 4.27 (2.76) 1.21–9.75 0.13
Consequences 0.02 (0.12) −0.23–0.26 0.90 0.02
Timeline −0.36 (0.26) −0.88–0.16 0.18 −0.13
Personal control −0.09 (0.12) −0.33–0.14 0.43 −0.10
Treatment control 0.29 (0.13) 0.02–0.56 0.03∗ 0.27
Identity −0.16 (0.09) −0.35–0.02 0.08 −0.19
Concern −0.08 (0.11) −0.30–0.15 0.50 −0.08
Understand 0.05 (0.11) −0.17–0.27 0.65 0.05
Emotional response 0.17 (0.10) −0.03–0.36 0.09 0.22
SMBG recommendations and illness perceptions 0.04∗ 0.14
Constant −4.77 (3.11) −10.94–1.40 0.13
Consequences 0.10 (0.13) −0.15–0.36 0.42 0.11
Timeline 0.66 (0.30) 0.07–1.25 0.03∗ 0.20
Personal control −0.04 (0.13) −0.29–0.21 0.75 −0.04
Treatment control 0.22 (0.15) −0.08–0.51 0.15 0.18
Identity 0.15 (0.10) −0.05–0.35 0.15 0.15
Concern −0.19 (0.12) −0.43–0.05 0.11 −0.18
Understand 0.15 (0.12) −0.10–0.39 0.24 0.12
Emotional response 0.05 (0.11) −0.16–0.27 0.62 0.06
Foot care recommendations and illness perceptions 0.01∗∗ 0.18
Constant 3.52 (2.73) −1.90–8.94 0.20
Consequences 0.15 (0.11) −0.07–0.38 0.17 0.18
Timeline −0.39 (0.26) −0.91–0.12 0.13 −0.14
Personal control 0.25 (0.11) 0.04–0.46 0.02∗ 0.25
Treatment control −0.17 (0.13) −0.42–0.07 0.17 −0.17
Identity 0.09 (0.09) −0.08–0.26 0.31 0.10
Concern −0.09 (0.10) −0.29–0.12 0.41 −0.09
Understand 0.28 (0.11) 0.06–0.49 ≤0.01∗∗ 0.26
Emotional response 0.06 (0.09) −0.12–0.25 0.50 0.08
Overall self-management recommendations and illness perceptions 0.003∗∗ 0.22
Constant 1.93 (1.44) −0.92–4.79 0.18
Consequences 0.03 (0.07) −0.10–0.16 0.66 0.06
Timeline −0.06 (0.14) −0.33–0.21 0.65 −0.04
Personal control 0.02 (0.06) −0.10–0.15 0.71 0.04
Treatment control 0.10 (0.07) −0.05–0.24 0.18 0.16
Identity −0.05 (0.05) −0.15–0.05 0.30 −0.11
Concern −0.07 (0.06) −0.18–0.05 0.30 −0.13
Understand 0.19 (0.06) 0.08–0.31 ≤0.001∗∗∗ 0.33
Emotional response 0.10 (0.05) −0.001–0.20 0.05∗ 0.23
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Table 3: Continued.
Predictor variable 𝐵 (SE) 95% CI 𝑝-value 𝛽 𝑅2
(2) Predicting self-management recommendations from self-efficacy (PDSMS score)
Diet recommendations and PDSMS score 0.03
Constant 3.50 (0.58) 2.35–4.65 <0.001∗∗∗
Diabetes self-efficacy 0.04 (0.02) −0.001–0.08 0.05∗ 0.18
Exercise recommendations and PDSMS score 0.03
Constant 0.88 (0.93) −0.96–2.73 0.34
Diabetes self-efficacy 0.06 (0.03) −0.00–0.13 0.05∗ 0.19
SMBG recommendations and PDSMS score 0.01
Constant 3.46 (1.06) 1.36–5.56 0.001∗∗∗
Diabetes self-efficacy 0.04 (0.04) −0.04–0.12 0.29 0.10
Foot care recommendations and PDSMS score 0.03
Constant 1.28 (0.94) −0.58–3.14 0.18
Diabetes self-efficacy 0.06 (0.03) −0.01–0.13 0.07 0.17
Overall SMG recommendations and PDSMS score 0.08
Constant 2.23 (0.48) 1.27–3.18 <0.001∗∗∗
Diabetes self-efficacy 0.05 (0.02) 0.02–0.09 <0.01∗∗ 0.29
∗
𝑝 value ≤ 0.05; ∗∗𝑝 value ≤ 0.01; ∗∗∗𝑝 value ≤ 0.001.
significantly explained participants’ degree of adherence to
exercise (9%), SMBG (21%), and overall self-management
(7%) recommendations.
Finally, both illness representations and self-efficacy
for diabetes self-management were significant predictors of
participants’ self-management behaviours. Illness represen-
tations explained 14% of adherence to SMBG, 18% of adher-
ence to foot care, and 22% of overall self-management recom-
mendations. Self-efficacy beliefs explained 3% each of adher-
ence to diet and exercise and 8% of overall self-management
recommendations.
3.2.2. Discussion of Findings. The gender distribution of the
sample reflects the slight differences in the overall prevalence
of diabetes in men (6.3%) and women (5.3%) in England (33)
and the age distribution of the sample is consistent with the
mixed sample of younger type 1 diabetes patients (mean age:
45.10; SD = 12.03) and older type 2 participants (mean age:
55.05; SD = 7.03).
The finding that illness representations predict self-man-
agement behaviours of this poorly controlled diabetes pop-
ulation shows that the Leventhal’s common sense model of
illness representation is fairly robust in explaining patients’
thoughts and reflections in their attempt to cope with a
health condition such as diabetes [33]. It also shows the
concept is applicable to a wide range of patients with diabetes,
irrespective of their demographic, cultural, or clinical profile
[9, 10, 24, 25]. Similar observations have been shown in
studies of other illness groups too. For example, a meta-
analysis examining the significance of illness perceptions on
attendance at cardiac rehabilitation following acute myocar-
dial infarction reported small but significant effect sizes of
the relationships between the two variables [21]. In relation to
specific components of the illness perception schema, meta-
analysis of the results found that greater perception of identity
or symptom load (𝑟 = 0.13;𝑝 value = 0.004), consequences
(𝑟 = 0.08, 𝑝 value = 0.012), and cure/control (𝑟 = 0.119, 𝑝
value < 0.001) were significantly associated with attendance
at cardiac rehabilitation [21].
The fact that longer duration since diagnosis was associ-
ated with longer timeline perceptions, greater understanding
(coherence) about diabetes and lower negative emotional
response is encouraging and reflects a situation where
patients have come to terms with the reality about their
condition and therefore doing their best to comprehend and
potentially confront the illness rather than allow themselves
to be weighed down by negative emotions.
Although somewhat expected, the finding that self-
efficacy significantly explains variations in adherence to self-
management behaviours is of immense practical importance.
Indeed, self-efficacy is a social cognitive concept which has
behavioural underpinnings including the motivation for the
individual to activate and persist on the behaviour even in
the face of difficulties, albeit depending on themagnitude and
strength of the efficacy expectations [11]. In part, self-efficacy
is driven by an individual’s expectations that behaving in a
particular way will yield benefits and/or avert difficulties in
the future. The motivation to initiate and sustain behaviour
could also be activated through themechanismof goal setting
and attainment, self-initiated or otherwise [34].
Our findings on self-efficacy and self-management
behaviours concur with the large body of literature which
consistently demonstrates associations between self-efficacy
and health-related behaviours. For example, in an ethnically
diverse, low income population with type 2 diabetes, Sarkar
and colleagues reported significant association between self-
efficacy and adherence to dietary, exercise, SMBG, and foot
care recommendations [35]. The associations observed in
their study persisted after adjusting for relevant clinical and
demographic variables. More recently, Walker and others
also reported moderately significant associations between
participants’ adherence to diet, exercise, foot care, and SMBG
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among low income and minority ethnic populations with
diabetes, both in univariate and multivariate (but not foot
care) analyses [15]. Indeed as found in our study others
[15, 35] have also shown significant associations between self-
efficacy and clinical disease outcomes such as HbA1c.
Interestingly, both psychological measures (the brief IPQ
and the PDSMS) identified persons with type 1 diabetes and
having been diagnosed with diabetes for a longer duration
to be associated with higher perceived confidence. On the
contrary, presence of neuropathy and high HbA1c were asso-
ciated with lower perceived confidence inmanaging diabetes.
Unfortunately, the cross-sectional nature of this study does
not permit us to make inferences about temporality of these
relationships. For instance, it is unclear whether individuals
are likely to become less confident after failing to bring their
HbA1c under control or developing diabetic complications
or vice versa. Nevertheless, this finding is useful and could
guide the identification of patients whomay benefit from self-
efficacy related interventions.
Our findings show that sociodemographic and disease
characteristics (mostly in the univariate analyses, but also a
few in themultivariate analyses) influenced adherence to self-
management recommendations in different ways. Exploring
such variations further could be useful for targeting and tai-
loring self-management interventions to specific population
groups [36, 37].
In terms of its implications for practice, the pivotal role of
self-efficacy in predicting or acting as a catalyst formotivating
the individual in the performance of a given task, including
health behaviour, implies that the concept could be used to
guide behaviour change and diabetes control intervention
in our study population, as has been demonstrated in other
populations with diabetes [12, 14]. As explained by Bandura
[11] the magnitude and intensity of self-efficacy possessed
by an individual could vary for different areas or aspects of
behaviour; it is therefore possible to identify any deficiencies
in an individual andwork towards augmenting them through
the provision of targeted skill training and education [38].
This approach could potentially work for poorly controlled
patients such as the participants in our study.
An obvious implication of the findings in relation to
illness representation is that illness representation in general
could be used as a framework to guide interventions aim-
ing at promoting appropriate self-management behaviours
among individuals with poorly controlled diabetes. Particu-
larly, interventions enhancing appropriate timeline, personal
control, and illness coherence components of the illness
perception schema could be useful. On the flip side, it is also
possible to use the illness perception concept as a screening
tool for identifying patients who, because of their illness
representations, are potentially less likely to adhere to self-
management recommendations and subsequently working to
alter these perceptions [20, 39].
This study has some limitations which should be con-
sidered in the interpretation of its findings. First, the small
sample size of the study (𝑛 = 123) means there is potential for
type II error. For example, considering the sample size calcu-
lation based on the 50 + 8𝑘 (𝑘=number of predictors) rule for
multiple regression analysis [40], we would have required
at least 128 complete responses for the multiple regression
analysis between self-management and the eight compo-
nents of illness representation. It is therefore likely that our
analyses failed to detect some associations. Secondly, the
participant information sheet for the main study explained
that the study was investigating work-related factors on
diabetes self-management. Invitation letters and study packs
were accordingly sent to all patients in the working age
range (25–65) as the hospital records did not contain this
information. Indeed, some patients returned questionnaires
uncompleted, some with notes explaining that they are not
in employment. It would therefore be misleading to present
statistics for response rates in this report. Also, data for both
predictor and outcome variables were collected at a single
time point (cross-sectional design). Cross-sectional studies
have several limitations, including the fact that we are unable
to infer causality and direction of effect in the associations
reported in this study. Further, data were collected using
postal questionnaires and some clinical data obtained from
routine hospital records. Both postal questionnaires and
routine data have their inherent limitations too. Nonetheless,
the findings from this small scale study are of critical imp-
ortance and further studies investigating the applicability of
illness representations and self-efficacy frameworks and their
practical underpinnings on the behaviour of exclusively
poorly controlled individuals with diabetes are warranted.
4. Conclusions
The concept of self-management is about helping patients
assume the day-to-day control of their illness with some
support from healthcare professionals. Thus we call for more
studies aimed at understanding the potential barriers and
promoters of self-management and good clinical control of
diabetes in predominantly poorly controlled diabetes popu-
lations such as our study sample, using psychological con-
structs such as those used in this study. Different forms of
reaching out to patients of varying ages and clinical and
demographic profiles including digital platformswhich could
be tailored to the circumstances of individuals may be appro-
priate.
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